More Intense Neoadjuvant ECX Regimen Fails for Esophageal Cancer More Intense Neoadjuvant ECX Regimen Fails for Esophageal Cancer
Dr Kerr reports on a large, well-designed trial with disappointing results.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
More News: Cancer | Cancer & Oncology | Esophagus Cancer | Health | Hematology | Neoadjuvant Therapy